C-kit mutations in core binding factor leukemias
Top Cited Papers
- 15 January 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 95 (2) , 726-728
- https://doi.org/10.1182/blood.v95.2.726
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Enhanced myeloid specificity of CD 117 compared with CD13 and CD33Leukemia Research, 1999
- Expression of the C-Kit Receptor (CD117) is a Feature of Almost All Subtypes of De Novo Acute Myeloblastic Leukemia (AML), Including Cytogenetically Good-Risk AML, and Lacks Prognostic SignificanceLeukemia & Lymphoma, 1999
- In VivoDifferentiation of Mast Cells from Acute Myeloid Leukemia Blasts Carrying a Novel Activating Ligand-Independent C-kit MutationBlood Cells, Molecules, and Diseases, 1998
- Expression of the c-kit (CD117) Molecule in Normal and Malignant HematopoiesisLeukemia & Lymphoma, 1998
- Acute Myelomonoblastic Leukemia Carrying the PEBP2β/MYH11 Fusion GeneLeukemia & Lymphoma, 1998
- Expression of Constitutively Activated Human c-Kit in Myb Transformed Early Myeloid Cells Leads to Factor Independence, Histiocytic Differentiation, and TumorigenicityBlood, 1997
- Myelomonoblastic leukaemia cells carrying the PEBP2β/MYH11 fusion gene are CD34+, c‐KIT+ immature cellsBritish Journal of Haematology, 1997
- Cellular Characteristics of Acute Myeloblasts Leukemia Associated with t(8;21)(q22;q22)Leukemia & Lymphoma, 1994
- Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cellsBlood, 1991
- Establishment of an immature mast cell line from a patient with mast cell leukemiaLeukemia Research, 1988